159 results
424B5
TPST
Tempest Therapeutics Inc
20 Jun 24
Prospectus supplement for primary offering
8:32am
or expense reimbursement payable to Jefferies under the terms of the sales agreement, will be approximately $400,000. The remaining sale proceeds
8-K
EX-4.1
vtrc4nd
11 Oct 23
Entry into a Material Definitive Agreement
8:13am
8-K
EX-10.1
i6ijx6pl9t252r57
29 Dec 22
Entry into a Material Definitive Agreement
4:06pm